HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro Gugliucci Selected Research

acetylsalicylic acid hydrolase

11/2010Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysis.
7/2010Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus.
5/2010Serum cholesterol concentration associated with aspirin esterase activity in older people: preliminary data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro Gugliucci Research Topics

Disease

12Atherosclerosis
06/2023 - 01/2005
11Obesity
01/2022 - 02/2016
10Inflammation (Inflammations)
03/2022 - 01/2008
10Insulin Resistance
02/2022 - 08/2016
9Chronic Kidney Failure (Chronic Renal Failure)
08/2023 - 02/2007
8Cardiovascular Diseases (Cardiovascular Disease)
06/2023 - 05/2010
8Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2021 - 02/2016
7Dyslipidemias (Dyslipidemia)
08/2023 - 01/2017
5Non-alcoholic Fatty Liver Disease
04/2021 - 08/2016
5Renal Insufficiency (Renal Failure)
03/2014 - 09/2007
4Type 2 Diabetes Mellitus (MODY)
01/2017 - 07/2010
3Fatty Liver
01/2019 - 08/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
07/2015 - 03/2014
2Hyperglycemia
03/2022 - 07/2005
2Diabetes Mellitus
03/2022 - 01/2005
2Hypoxia (Hypoxemia)
11/2018 - 12/2005
2Diabetes Complications
08/2016 - 07/2005
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 01/2005
2Stroke (Strokes)
03/2014 - 01/2014
2Nervous System Diseases (Neurological Disorders)
03/2014 - 04/2012
2Acute Coronary Syndrome
09/2011 - 12/2005
2Overweight
11/2009 - 01/2009
2Weight Loss (Weight Reduction)
11/2009 - 01/2009
1Chronic Renal Insufficiency
02/2023
1Body Weight (Weight, Body)
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
11/2021
1Anemia
05/2021
1Iron Overload
05/2021
1Metabolic Diseases (Metabolic Disease)
01/2018
1Pediatric Obesity
01/2018
1Asthma (Bronchial Asthma)
01/2017
1Chronic Bronchitis
01/2017
1Arthritis (Polyarthritis)
01/2017
1Hypertriglyceridemia
10/2016
1Hyperinsulinism (Hyperinsulinemia)
02/2016
1Chronic Disease (Chronic Diseases)
07/2015

Drug/Important Bio-Agent (IBA)

16Aryldialkylphosphatase (Paraoxonase)IBA
08/2023 - 02/2007
8Triglycerides (Triacylglycerol)IBA
08/2023 - 01/2009
8FructoseIBA
08/2023 - 02/2016
8Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2005
6Advanced Glycation End ProductsIBA
01/2019 - 01/2009
5Lipoproteins (Lipoprotein)IBA
08/2023 - 01/2012
5LipidsIBA
06/2023 - 07/2010
5oxidized low density lipoproteinIBA
01/2023 - 11/2009
5Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2005
5arylesteraseIBA
11/2021 - 09/2008
5Pyruvaldehyde (Methylglyoxal)IBA
01/2019 - 04/2012
4SugarsIBA
08/2023 - 07/2005
4Glucose (Dextrose)FDA LinkGeneric
08/2023 - 07/2010
4ChylomicronsIBA
08/2023 - 09/2020
4ischemia-modified albuminIBA
11/2018 - 12/2005
4HDL CholesterolIBA
01/2018 - 11/2009
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2023 - 01/2023
3CholesterolIBA
06/2023 - 01/2018
3Apolipoprotein C-IIIIBA
02/2022 - 10/2016
3AntioxidantsIBA
11/2021 - 01/2013
3acetylsalicylic acid hydrolaseIBA
11/2010 - 05/2010
3Acrolein (Aqualin)IBA
02/2008 - 01/2007
2ResistinIBA
01/2022 - 05/2010
2AdiponectinIBA
01/2022 - 01/2022
2AdipokinesIBA
01/2022 - 01/2022
2Interleukin-6 (Interleukin 6)IBA
08/2021 - 05/2021
2Dietary SugarsIBA
01/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2019 - 08/2016
2Receptor for Advanced Glycation End ProductsIBA
01/2019 - 07/2015
2Lactic Acid (Lactate)FDA LinkGeneric
01/2019 - 01/2018
2Insulin (Novolin)FDA Link
01/2018 - 01/2017
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2018 - 01/2011
2Peroxidase (Myeloperoxidase)IBA
01/2015 - 03/2014
2LigandsIBA
01/2014 - 04/2012
2HDL LipoproteinsIBA
01/2011 - 01/2005
2Cholinesterases (Cholinesterase)IBA
11/2010 - 07/2010
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2010 - 05/2010
1VLDL LipoproteinsIBA
01/2023
1Angiopoietin-Like Protein 3IBA
02/2022
1Chylomicron RemnantsIBA
02/2022
1CytokinesIBA
01/2022
1Fatty Acid-Binding ProteinsIBA
01/2022
1LeptinIBA
01/2022
1EnzymesIBA
11/2021
1Dietary FiberFDA Link
08/2021
1Ferritins (Ferritin)IBA
05/2021
1Hormones (Hormone)IBA
05/2021
1IronIBA
05/2021
1HepcidinsIBA
05/2021
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
09/2020
1Apolipoprotein B-48IBA
09/2020
1Uric Acid (Urate)IBA
01/2019
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019
1Phosphates (Orthophosphate)IBA
01/2018
1AMP-Activated Protein KinasesIBA
01/2017
1Metformin (Glucophage)FDA LinkGeneric
08/2016
1Starch (Cornstarch)IBA
02/2016
1ApolipoproteinsIBA
10/2014
1Apolipoproteins E (ApoE)IBA
10/2014

Therapy/Procedure

5Renal Dialysis (Hemodialysis)
09/2011 - 02/2007
2Therapeutics
06/2023 - 04/2012
1Renal Replacement Therapy (Therapies, Renal Replacement)
08/2023
1Phytotherapy (Herbal Therapy)
03/2022
1Secondary Prevention
01/2015